
Medtech company Boston Scientific, which is one of Ambu's competitors on the market for single-use scopes, has acquired Baylis Medical Company for USD 1.75bn, Bloomberg News reports.
Boston Scientific states that the companies have entered into a binding agreement, and the deal is expected to be finalized during the first quarter of 2022.
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app